315 related articles for article (PubMed ID: 24465898)
1. The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme.
Wang E; Zhang C; Polavaram N; Liu F; Wu G; Schroeder MA; Lau JS; Mukhopadhyay D; Jiang SW; O'Neill BP; Datta K; Li J
PLoS One; 2014; 9(1):e86102. PubMed ID: 24465898
[TBL] [Abstract][Full Text] [Related]
2. Factor inhibiting HIF1α (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1α pathway.
Chen T; Ren Z; Ye LC; Zhou PH; Xu JM; Shi Q; Yao LQ; Zhong YS
Cancer Biol Ther; 2015; 16(2):244-52. PubMed ID: 25602156
[TBL] [Abstract][Full Text] [Related]
3. Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1alpha.
Lee YM; Lim JH; Chun YS; Moon HE; Lee MK; Huang LE; Park JW
Carcinogenesis; 2009 Oct; 30(10):1768-75. PubMed ID: 19696166
[TBL] [Abstract][Full Text] [Related]
4. HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo.
Fiorenzo P; Mongiardi MP; Dimitri D; Cozzolino M; Ferri A; Montano N; Trevisi G; Maira G; Battistini L; Falchetti ML; Levi A; Pallini R
Int J Oncol; 2010 Apr; 36(4):785-91. PubMed ID: 20198320
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].
Stolze IP; Tian YM; Appelhoff RJ; Turley H; Wykoff CC; Gleadle JM; Ratcliffe PJ
J Biol Chem; 2004 Oct; 279(41):42719-25. PubMed ID: 15302861
[TBL] [Abstract][Full Text] [Related]
6. NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme.
Hsieh CH; Shyu WC; Chiang CY; Kuo JW; Shen WC; Liu RS
PLoS One; 2011; 6(9):e23945. PubMed ID: 21935366
[TBL] [Abstract][Full Text] [Related]
7. Ferritin heavy chain controls the HIF-driven hypoxic response by activating the asparaginyl hydroxylase FIH.
Jin P; Kang J; Lee MK; Park JW
Biochem Biophys Res Commun; 2018 May; 499(3):475-481. PubMed ID: 29580991
[TBL] [Abstract][Full Text] [Related]
8. Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.
Agrawal R; Pandey P; Jha P; Dwivedi V; Sarkar C; Kulshreshtha R
BMC Genomics; 2014 Aug; 15(1):686. PubMed ID: 25129238
[TBL] [Abstract][Full Text] [Related]
9. Isolinderalactone suppresses human glioblastoma growth and angiogenic activity in 3D microfluidic chip and in vivo mouse models.
Park JH; Kim MJ; Kim WJ; Kwon KD; Ha KT; Choi BT; Lee SY; Shin HK
Cancer Lett; 2020 May; 478():71-81. PubMed ID: 32173479
[TBL] [Abstract][Full Text] [Related]
10. Ankyrin Repeat Proteins of Orf Virus Influence the Cellular Hypoxia Response Pathway.
Chen DY; Fabrizio JA; Wilkins SE; Dave KA; Gorman JJ; Gleadle JM; Fleming SB; Peet DJ; Mercer AA
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795413
[TBL] [Abstract][Full Text] [Related]
11. The chromatin remodeler ISWI regulates the cellular response to hypoxia: role of FIH.
Melvin A; Mudie S; Rocha S
Mol Biol Cell; 2011 Nov; 22(21):4171-81. PubMed ID: 21900490
[TBL] [Abstract][Full Text] [Related]
12. [Growth Regulation of Factor Inhibiting Hypoxia-Inducible Factor in Renal Carcinoma Cells].
Deng S; Yang B; Ren ZJ; Dong Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):29-33. PubMed ID: 29737085
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the
Cai X; Zhang D; Wang J; Liu X; Ouyang G; Xiao W
J Biol Chem; 2018 Oct; 293(40):15370-15380. PubMed ID: 30126845
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of nuclear factor-kappaB alpha derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1alpha.
Shin DH; Li SH; Yang SW; Lee BL; Lee MK; Park JW
FEBS J; 2009 Jul; 276(13):3470-80. PubMed ID: 19456861
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer.
Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB
Breast Cancer Res; 2007; 9(6):R89. PubMed ID: 18096060
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
17. Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.
Nigim F; Cavanaugh J; Patel AP; Curry WT; Esaki S; Kasper EM; Chi AS; Louis DN; Martuza RL; Rabkin SD; Wakimoto H
J Neuropathol Exp Neurol; 2015 Jul; 74(7):710-22. PubMed ID: 26083570
[TBL] [Abstract][Full Text] [Related]
18. The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines.
Macharia LW; Muriithi W; Heming CP; Nyaga DK; Aran V; Mureithi MW; Ferrer VP; Pane A; Filho PN; Moura-Neto V
BMC Cancer; 2021 Nov; 21(1):1248. PubMed ID: 34798868
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1.
Shin DH; Chun YS; Lee DS; Huang LE; Park JW
Blood; 2008 Mar; 111(6):3131-6. PubMed ID: 18174379
[TBL] [Abstract][Full Text] [Related]
20. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha.
Dayan F; Roux D; Brahimi-Horn MC; Pouyssegur J; Mazure NM
Cancer Res; 2006 Apr; 66(7):3688-98. PubMed ID: 16585195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]